HONG KONG SAR - Media OutReach - 20 October 2021 - The developer behind a
portfolio of four purpose-built, premium nursing homes costing €127m
(HKD1.15bn) in Ireland is expanding its healthcare business to provide more
much-needed nursing home beds and is well-positioned to fundraise the
construction costs from Asia investors through the Immigrant Investor Programme
(IIP).
Bartra Healthcare, a
subsidiary of Bartra Group, is adding Cookstown Tallaght, a €33m nursing home
project (Phase Five) in South Dublin to its portfolio. The Group's subsidiary, Bartra Wealth
Advisors launched the project globally on 15 October to its IIP clients
across Hong Kong and Shanghai in China, and Ho Chi Minh City in Vietnam, and
managed to snap up €6m in two weeks at the project 'pre-launch' stage.
James Hartshorn, CEO and
Co-founder of Bartra Wealth Advisors commented, "We are glad to see our hard
work has paid off. Many high-net-worth clients in Asia would like to immigrate
to Ireland and they are confident in the IIP and Bartra's nursing home projects
on four fronts.
Firstly, Ireland is a
rising star in Europe where it provides excellent education to children, which
leads to good future job prospects as a result of its growing economy as well
as opportunities in EU countries, the UK and the US. Secondly, the IIP provides
fast track permanent residency status with great flexibility on residing
requirements as applicants can immigrate without relocating. Thirdly, our integrated
business model makes our clients feel safe. We are the only nursing home
developer in the Irish healthcare sector to source, build and manage projects
from start to finish as well as provide clinical care premium services. In Hong
Kong and other major cities in China, and in Vietnam, we provide our clients
with direct investment opportunities into our IIP projects including nursing
homes. Finally, all the nursing home projects are carefully sourced and built
in key Dublin urban locations where they benefit from excellent transport links
and proximity to major hospitals.
These locations have a
high demand for nursing home beds and the projects are built to meet the
highest Irish Government (HIQA) and EU standards, qualifying Bartra Healthcare
homes for government supported revenue models. Investing in our projects is not
only very safe, but also capital guaranteed with a 4% annual interest rate, all
factors favoured by our Asian clients."
Ireland has become an
on-demand immigration hotspot in Asia as an alternative to the UK, the US and
other English-speaking countries. Affluent families are drawn to its
outstanding quality of education and living standards as well as its
accessibility to the EU and the UK (under the CTA Agreement), strong transport
links to Europe and the US, and strong economic growth that perennially puts Ireland
ahead of its European peers. Many industries such as pharmaceuticals,
innovation and technology, and the financial sectors are fast-growing, with
more foreign companies coming into Ireland to set up European headquarters and
ensuring a thriving job market. All these factors make Ireland one of the
world's immigration hotspots.
Additionally in Ireland, the Irish nursing home sector is facing a major
shortage of beds thanks to years of under-investment following the recession in
2008. Because of this lack of beds, and coupled with Ireland's ageing
population where more than 15% of the population is now aged over 65, the
demand for nursing home facilities is huge. CBRE's 2021 report outlined that
Ireland needs to build an extra 15 thousand nursing home beds over the next
nine years to service this growing elderly population.
This has led the Irish
government to prioritise IIP investment in the delivery of critically needed
nursing home accommodation. In Ireland, the Health Service Executive ("HSE") also
supports the private nursing home sector through the Irish Government's Nursing
Home Support Scheme (also known as the "Fair Deal Scheme") which provides
approximately 80% of the income for private nursing homes.
Bartra Healthcare
was established in response to the acute and high demand for nursing home care
in Ireland and is on course to become the largest private-sector provider with
a portfolio of over 1,000 beds across at least 10 nursing homes. Bartra
Healthcare has four projects in its nursing home portfolio, three of which are
already in operation, while construction is ongoing on the fourth home,
providing a total of 608 beds and costing approximately €127m. The latest
project, Cookstown Tallaght in South Dublin, will provide a 131-bed nursing
home, together with a pharmacy and cafe, and is expected to commence
construction in 2022. The site is located in the heart of Tallaght, a thriving
urban hub with a population of 80,000 making it one of Dublin's largest suburbs,
where it also benefits from excellent transport links – the Belgard Luas light
rail station is just 250 metres away, providing access for both staff and the
families of residents. It also boasts proximity to major hospitals, including
Tallaght University Hospital, Ireland's leading academic teaching hospital,
which is less than a kilometre away, and St James's Hospital, just 8km away.
The total cost of the
latest project is approximately €33m and Bartra is seeking €20m investor loans
(5-year term, 4% annual interest) from IIP applicants to fund construction. In
the two weeks prior to the official launch on 15 October, €6m was secured from
IIP investors in Hong Kong and Ho Chi Minh City managed by Bartra's immigration
arm Bartra Wealth Advisors.
Jeffrey Ling,
Bartra Wealth Advisors Regional Director commented on the advantages of
Bartra's IIP nursing home projects during a Hong Kong seminar: "We are the only
group that integrates development, operation and management in the IIP, run and
managed by a dedicated division – Bartra Healthcare. Bartra's nursing
homes are safe, authorised and much-needed projects in Ireland, and they have a
state-backed revenue steam. We are committed to the home quality and to
providing our clients principal repayment and 4% interest per annum. The scheme
is extremely popular among our Hong Kong clients, who said they can use the 20%
interest obtained at maturity, which is circa HK$2 million, to pay their
children's education fees or to buy property in Ireland."
The issuer is solely responsible for the content of this announcement.